[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646495":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":22,"responsibleParty":40,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":7,"maxAge":7,"enrollmentInfo":51,"targetDuration":54,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Charite University, Berlin, Germany","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Lena-Luise Becker, Dr. med.","Charité- Universitätsmeidzin Berlin- Neuropediatrics","PRINCIPAL_INVESTIGATOR",[14,18],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","0049 03 450 566 122","lena-luise.becker@charite.de",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Angela M. Kaindl, Prof. Dr.","0049 03 450 566 112","angela.kaindl@charite.de",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Charité- Universitätsmedizin Berlin- Neuropediatrics","RECRUITING","Berlin","State of Berlin","13353","Germany","DE",{"type":32,"coordinates":33},"Point",[34,35],13.41053,52.52437,{"lat":35,"lon":34},[38],{"name":10,"role":15,"phone":39,"phoneExt":7,"email":17},"0049 30 450 566 112",{"type":12,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Lena-Luise Becker","Principal Investigator","100646495","international-registry-for-trpm3-associated-disorders-100646495",false,"NCT07690111","International Registry for TRPM3-associated Disorders","TRPM3Care","Inclusion Criteria:\n\n* Variant in the TRPM3 gene\n\nExclusion Criteria:\n\n* no consent from patient\u002Ffamiliy","ALL",{"count":52,"type":53},100,"ESTIMATED","10 Years","OBSERVATIONAL","The goal of the TRPM3Care-registry is to record the disease progression of patients with TRPM3-associated disorders. This allows us to compare the disease progression and the success of different therapies, as well as to examine their impact on quality of life.",[58],"TRPM3",[58],"2026-07-02",{"date":62,"type":63},"2026-07-08","ACTUAL",{"date":65,"type":63},"2026-01-01",{"date":67,"type":53},"2036-12-31",{"name":5,"class":6},1]